Minimal-change nephropathy in systemic lupus erythematosus.

1. Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 2010;7(11):611-9. 2. Tischendorf JJ, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol 2007;102:107-14. 3. Montini G, Carasi C, Zancan L, Dall'Amico R, Murer L, Zacchello G, et al. Chronic cholestatic liver disease with associated tubulointerstitial nephropathy in early childhood. Pediatrics 1997;100(3):E10. 4. Neuhaus TJ, Stallmach T, Leumann E, Altorfer J, Braegger CP. Familial progressive tubulo-interstitial nephropathy and cholestatic liver disease-a newly recognized entity? Eur J Pediatr 1997;156(9):723-6. 5. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008;14(25):3948-55. 6. Patel SM, Szostek JH. IgG4-related systemic disease in a native American man. Intern Med 2011;50:931-4. 7. Ebbo M, Grados A, Daniel L, Vély F, Harlé JR, Pavic M, et al. IgG4-related systemic disease: emergence of a new systemic disease? Literature review. Rev Med Interne 2012;33(1):23-34. 8. Angulo P, Peter JB, Gershwin ME. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000;32:182. 9. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow-up of autoimmune pancreatitis: A systematic literature review and metaanalysis. J Gastroenterol 2009;24:15-36.